UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061549
Receipt number R000070429
Scientific Title Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial
Date of disclosure of the study information 2026/05/13
Last modified on 2026/05/13 11:29:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial

Acronym

Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial

Scientific Title

Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial

Scientific Title:Acronym

Effect of Lung-Protective Ventilation During General Anesthesia on the Reduction of Complication Incidence and Airway Patency: A Randomized Controlled Trial

Region

Japan


Condition

Condition

Minor surgical conditions, primarily including superficial bladder cancer

Classification by specialty

Anesthesiology Operative medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To demonstrate that the use of lung-protective ventilation during general anesthesia reduces upper airway-related complications.
To evaluate the effects of lung-protective ventilation on the upper airway, particularly on glottic patency.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of capnography-detected abnormalities in end-tidal carbon dioxide waveforms immediately after neuromuscular blockade reversal under supraglottic airway device management

Key secondary outcomes

Glottic angle observed fiberoptically through a supraglottic airway device


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Lung-protective ventilation group (5 mL/kg)

Interventions/Control_2

Conventional ventilation group (8 mL/kg)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Adults aged >=18 years at the time of consent.
2)Adult patients scheduled to undergo minor surgical procedures under general anesthesia managed with a supraglottic airway device.
3)Patients who have received a full explanation of the study, have adequately understood it, and have provided written informed consent voluntarily.

Key exclusion criteria

Patients meeting any of the following criteria:

1)Patients whose upper airway is managed with devices other than a supraglottic airway device.
2)Patients who have withdrawn consent and expressed refusal to participate in this study.
3)Patients with severe hepatic dysfunction.
4)Patients in whom succinylcholine is contraindicated.
5)Patients deemed unsuitable for the study by the principal investigator.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Katsuhiko
Middle name
Last name Ishibashi

Organization

Institute of Science Tokyo Hospital

Division name

Anesthesiology

Zip code

113-8510

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-6111

Email

ishibashi.k.3dd4@m.isct.ac.jp


Public contact

Name of contact person

1st name Katsuhiko
Middle name
Last name Ishibashi

Organization

Institute of Science Tokyo Hospital

Division name

Anesthesiology

Zip code

113-8510

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-6111

Homepage URL


Email

ishibashi.k.3dd4@m.isct.ac.jp


Sponsor or person

Institute

Institute of Science Tokyo

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Research Ethics Committee of Institute of Science Tokyo

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan

Tel

03-5803-4547

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

jRCT1030250783

Org. issuing International ID_1

Japan Registry of Clinical Trials

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京科学大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 03 Month 06 Day

Date of IRB

2026 Year 02 Month 24 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 13 Day

Last modified on

2026 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070429